BR9810981A - Medicamento contendo ioimbina e arginina para tratamento de disfunção erétil - Google Patents

Medicamento contendo ioimbina e arginina para tratamento de disfunção erétil

Info

Publication number
BR9810981A
BR9810981A BR9810981-2A BR9810981A BR9810981A BR 9810981 A BR9810981 A BR 9810981A BR 9810981 A BR9810981 A BR 9810981A BR 9810981 A BR9810981 A BR 9810981A
Authority
BR
Brazil
Prior art keywords
yohimbine
arginine
erectile dysfunction
containing medication
treat erectile
Prior art date
Application number
BR9810981-2A
Other languages
English (en)
Inventor
Philippe Gorny
Original Assignee
Real 2000 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Real 2000 Ltd filed Critical Real 2000 Ltd
Publication of BR9810981A publication Critical patent/BR9810981A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"MEDICAMENTO CONTENDO IOIMBINA E ARGININA PARA TRATAMENTO DE DISFUNSãO ERéTIL" A presente invenção refere-se ao uso em combinação de ioimbina e arginina como ingredientes ativos para preparar um medicamento para tratar distúrbio erétil. A combinação tem um efeito sinergístico marcante.
BR9810981-2A 1997-07-04 1998-07-06 Medicamento contendo ioimbina e arginina para tratamento de disfunção erétil BR9810981A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9708504A FR2765483B1 (fr) 1997-07-04 1997-07-04 Medicament destine a traiter les dysfonctions erectiles
PCT/FR1998/001438 WO1999001132A1 (fr) 1997-07-04 1998-07-06 Medicament, contenant de la yohimbine et de l'arginine, destine a traiter les dysfonctions erectiles

Publications (1)

Publication Number Publication Date
BR9810981A true BR9810981A (pt) 2000-08-15

Family

ID=9508874

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810981-2A BR9810981A (pt) 1997-07-04 1998-07-06 Medicamento contendo ioimbina e arginina para tratamento de disfunção erétil

Country Status (17)

Country Link
US (1) US20020155136A1 (pt)
EP (1) EP1001775B1 (pt)
JP (1) JP2002511875A (pt)
KR (1) KR20010021505A (pt)
CN (1) CN1261798A (pt)
AT (1) ATE212841T1 (pt)
AU (1) AU743825B2 (pt)
BR (1) BR9810981A (pt)
CA (1) CA2295916A1 (pt)
DE (1) DE69803773T2 (pt)
DK (1) DK1001775T3 (pt)
ES (1) ES2172171T3 (pt)
FR (1) FR2765483B1 (pt)
ID (1) ID24184A (pt)
IL (1) IL133443A0 (pt)
PT (1) PT1001775E (pt)
WO (1) WO1999001132A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323211B1 (en) * 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
DE19831263A1 (de) * 1998-07-11 2000-01-13 Lohmann Therapie Syst Lts Darreichungsform
EE05315B1 (et) * 1999-09-03 2010-08-16 Eli Lilly And Company Dapoksetiini v?i selle farmatseutiliselt vastuv?etava soola kasutamine ravimi valmistamiseks, mis on ette n„htud imetajal esineva seksuaalse funktsioonih„ire ravimiseks v?i m?jutamiseks
DK1086695T3 (da) * 1999-09-21 2005-04-25 Enzo Leone Antivirale præparater omfattende yohimbin som aktivt princip
US6565851B2 (en) * 2000-05-26 2003-05-20 Horphag Research Limited Relieving symptoms of erectile dysfunction with proanthocyanidins
KR20010016165A (ko) * 2000-11-16 2001-03-05 정순학 성기능 장애 치료를 위한 피부에 적용하는 제제
ITMI20020990A1 (it) * 2002-05-10 2003-11-10 Indena Spa Formulazioni utili nel trattamento dell'impotenza maschile e femminile
ITMI20020994A1 (it) * 2002-05-10 2003-11-10 Indena Spa Formulazioni utili nel trattamento dell'impotenza maschile e femminile
HUP0401422A2 (en) 2004-07-15 2006-04-28 G Laszlo Meszaros Use of l-arginine as vasoaktive ingredient absorbing through skin for external application
DE102005053241A1 (de) * 2005-11-08 2007-05-16 Schwabe Willmar Gmbh & Co Extrakte aus der Rinde von Corynanthe-Arten und deren Verwendung sowie diese Extrakte enthaltende Arzneimittel, diätetische Lebensmittel und pharmazeutische Zubereitungen
CN111840508A (zh) * 2020-07-17 2020-10-30 北京清大赛尔生物科技有限公司 一种预防及治疗男性性功能障碍的外用制剂及其应用
CN113116905A (zh) * 2021-04-20 2021-07-16 北京天玺宝科技有限公司 一种增强男性性功能并持续改善性功能障碍的组合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response

Also Published As

Publication number Publication date
FR2765483B1 (fr) 2000-02-04
IL133443A0 (en) 2001-04-30
ATE212841T1 (de) 2002-02-15
AU743825B2 (en) 2002-02-07
CN1261798A (zh) 2000-08-02
PT1001775E (pt) 2002-07-31
US20020155136A1 (en) 2002-10-24
DE69803773D1 (de) 2002-03-21
CA2295916A1 (en) 1999-01-14
KR20010021505A (ko) 2001-03-15
JP2002511875A (ja) 2002-04-16
FR2765483A1 (fr) 1999-01-08
WO1999001132A1 (fr) 1999-01-14
ES2172171T3 (es) 2002-09-16
ID24184A (id) 2000-07-13
AU8446798A (en) 1999-01-25
DK1001775T3 (da) 2002-04-29
DE69803773T2 (de) 2002-08-29
EP1001775B1 (fr) 2002-02-06
EP1001775A1 (fr) 2000-05-24

Similar Documents

Publication Publication Date Title
BR9810981A (pt) Medicamento contendo ioimbina e arginina para tratamento de disfunção erétil
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
ES2177084T3 (es) Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso.
AR023130A1 (es) Composiciones para promover el crecimiento
ATE242633T1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
ATE321529T1 (de) Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
MX9306295A (es) Composiciones farmaceuticas para tratar sintomas de resfriado.
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
SE9701161D0 (sv) New use I
ES2178405T3 (es) Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
CY1106702T1 (el) Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
AR015537A1 (es) Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina.
BR9708037A (pt) Método para o tratamento de abuso de substância
IL156144A0 (en) Novel therapeutic use of a thienylcyclohexylamine derivative
MY136408A (en) Active substance combinations and therapies for treating abuse of alcohol
PT1313500E (pt) Associacoes de dalfopristina/quinupristina com o cefpirome
ES2187440T3 (es) Utilizacion de orosomucoide en un preparado farmaceutico para el tratamiento de pancreatitis aguda.
UY26735A1 (es) Métodos y composiciones para tratar flavivirus y pestivirus

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A,8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.